This inventor holds 1 USPTO granted patent. Top assignees: Ablynx N.v., Vectura Gmbh. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 174 
1 out of 71 Years Active: 2020
Title: Maria-Laura Sargentini: Innovator in RSV Treatment
Introduction
Maria-Laura Sargentini is a notable inventor based in Brussels, Belgium. She has made significant contributions to the field of medicine, particularly in the treatment of respiratory syncytial virus (RSV) infections in young children. Her innovative approaches have the potential to improve health outcomes for vulnerable populations.
Latest Patents
Maria-Laura Sargentini holds 1 patent for her work titled "Methods of treating RSV infections." This patent outlines methods for treating RSV infections in young children. Specifically, it describes the administration of polypeptides that bind to the F protein of human RSV, which neutralizes the infection when delivered to the lungs of young children at specific dose regimens.
Career Highlights
Throughout her career, Maria-Laura has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Ablynx N.V. and Vectura GmbH. Her work in these organizations has allowed her to develop and refine her innovative methods for treating RSV.
Collaborations
Maria-Laura has collaborated with several professionals in her field, including Koen Allosery and Erik Depla. These collaborations have contributed to her research and the advancement of her patented methods.
Conclusion
Maria-Laura Sargentini is a pioneering inventor whose work in RSV treatment showcases her dedication to improving pediatric health. Her innovative methods and collaborations highlight her significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile